{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-046957","form_type":"8-K","ticker":"RMTI","cik":"0001041024","company_name":"ROCKWELL MEDICAL, INC.","filed_at":"2025-05-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:47.266579+00:00","generated_at":"2026-05-21T22:43:36.301837+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Rockwell Medical Q1 net sales $18.9M (-17% YoY); net loss improves to $1.5M","bullets":["Net sales fell 17% to $18.9M, driven by largest customer transitioning to another supplier.","Received a one-time non-refundable payment of $0.9M from that customer to ensure supply continuity.","Net loss improved 12% to $1.5M ($0.04 loss per share) vs $1.7M in Q1 2024.","Adjusted EBITDA was -$0.4M; cash and investments $17.3M, down $4.3M from year-end 2024.","Reaffirmed 2025 guidance: net sales $65M-$70M, gross margin 16%-18%, adjusted EBITDA -$0.5M to $0.5M."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-046957","json":"https://secwatch.observer/filing/0001104659-25-046957.json","markdown":"https://secwatch.observer/filing/0001104659-25-046957.md","text":"https://secwatch.observer/filing/0001104659-25-046957.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1041024/000110465925046957/0001104659-25-046957-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1041024/000110465925046957/tm2514651d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-21T22:43:36.301837+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}